CBIZ Investment Advisory Services’s Gilead Sciences GILD Stock Holding History

CBIZ Investment Advisory Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.7K	Sell	615 -209	-25%	-$29.3K	﹤0.01%	63
2025 Q4	$101K	Buy	824 +604	+275%	+$73.4K	﹤0.01%	85
2025 Q3	$24.4K	Buy	220 +106	+93%	+$12K	﹤0.01%	227
2025 Q2	$12.6K	Sell	114 -20	-15%	-$2.13K	﹤0.01%	317
2025 Q1	$15K	Buy	134 +91	+212%	+$9.39K	﹤0.01%	268
2024 Q4	$3.94K	Buy	43 +23	+115%	+$2.07K	﹤0.01%	335
2024 Q3	$1.73K	Hold	20	–	–	﹤0.01%	353
2024 Q2	$1.4K	Hold	20	–	–	﹤0.01%	348
2024 Q1	$1.48K	Buy	+20	New	+$1.54K	﹤0.01%	314
2021 Q2	–	Hold	0	–	–	–	90
2021 Q1	–	Hold	0	–	–	–	81
2020 Q4	–	Hold	0	–	–	–	100
2020 Q3	–	Hold	0	–	–	–	102
2020 Q2	–	Hold	0	–	–	–	87
2020 Q1	–	Hold	0	–	–	–	121
2019 Q4	–	Hold	0	–	–	–	120

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CBIZ Investment Advisory Services's GILD Position: Q1 2026 in Review

CBIZ Investment Advisory Services reduced its Gilead Sciences (GILD) stake by 25% in Q1 2026, selling an estimated $29.3K and leaving 615 shares worth $85.7K. The position accounts for ﹤0.01% of the portfolio, ranked #63.

CBIZ Investment Advisory Services first reported a position in GILD in Q1 2024 and has held it in 9 quarters since. The position peaked at $101K in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

CBIZ Investment Advisory Services held 615 shares of Gilead Sciences worth $85.7K as of Q1 2026.
CBIZ Investment Advisory Services sold 209 Gilead Sciences shares in Q1 2026, an estimated $29.3K.
Gilead Sciences made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q1 2026, its #63 holding.
CBIZ Investment Advisory Services first reported a position in Gilead Sciences in Q1 2024 and has held it in 9 quarters since.
CBIZ Investment Advisory Services's Gilead Sciences position peaked at $101K in Q4 2025.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.